You are here

Insilico

Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial

Clinical Trials Arena

Thu, 12/7/23 - 10:13 am

ulcerative colitis

clinical trials

First Human Trials Begin for AI-Designed Drug

The Daily Upside

Mon, 06/26/23 - 08:39 pm

clinical trials

artificial intelligence

Sanofi Reaffirms Commitment to AI Drug Discovery with $1.2B Insilico Pact

BioSpace

Tue, 11/8/22 - 10:30 pm

artificial intelligence

Insilico's AI Identifies Potential New Therapeutic Targets for ALS

BioSpace

Sun, 07/10/22 - 11:56 pm

artificial intelligence

Biotech's top 10 money raisers of 2021

Fierce Biotech

Mon, 04/18/22 - 11:02 am

Laronde Therapeutics

Adagio Therapeutics

Sonoma Biotherapeutics

Venture investors still love drug developers

EP Vantage

Tue, 07/6/21 - 10:32 am

venture capital

Adagio Therapeutics

Umoja Biopharma

Nikang Therapeutics

Apollo Therapeutics

Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021

Endpoints

Wed, 02/24/21 - 11:07 am

artificial intelligence

'Longevity as a service': Insilico spins off AI biotech that trains deep learning on anti-aging treatments

Endpoints

Wed, 07/15/20 - 10:12 am

artificial intelligence

drug development

Pfizer teams up with Insilico to mine data for drug targets

Fierce Biotech

Thu, 01/16/20 - 10:09 am

real world evidence

Billions of Dollars This Week Show AI Is in BioPharma’s Present and Future

BioSpace

Sat, 01/12/19 - 11:23 am

artificial intelligence

Charles River Laboratories

Insilico, Juvenescence and the Buck Institute form AI-based venture to tackle metabolism and aging-related diseases

Fierce Biotech

Tue, 08/14/18 - 06:41 pm

artificial intelligence

AI And Biotech Companies In The East And West Invest In Combating Aging

Forbes

Tue, 06/12/18 - 10:35 pm

artificial intelligence